N Duverger

Summary

Country: France

Publications

  1. ncbi Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits
    N Duverger
    Rhône Poulene Rorer Gencell division, Atherosclerosis Department, Centre de Recherebe de Vitry Alfortville, Vitry sor Seine, France
    Circulation 94:713-7. 1996
  2. ncbi Transgenic rabbits expressing human apolipoprotein A-I in the liver
    N Duverger
    Rhône Poulenc Rorer Gencell, Atherosclerosis Department, Centre de Recherche de Vitry Alfortville, Vitry sur Seine, France
    Arterioscler Thromb Vasc Biol 16:1424-9. 1996
  3. ncbi Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha
    A Mamontova
    INSERM U141 and IFR Circulation Lariboisière, Rhone Poulenc Rorer, Gencell Division, Atherosclerosis Department, Centre de recherches de Vitry Alfortville, France
    Circulation 98:2738-43. 1998

Collaborators

Detail Information

Publications3

  1. ncbi Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits
    N Duverger
    Rhône Poulene Rorer Gencell division, Atherosclerosis Department, Centre de Recherebe de Vitry Alfortville, Vitry sor Seine, France
    Circulation 94:713-7. 1996
    ..The rabbit is a good animal model for human atherosclerosis...
  2. ncbi Transgenic rabbits expressing human apolipoprotein A-I in the liver
    N Duverger
    Rhône Poulenc Rorer Gencell, Atherosclerosis Department, Centre de Recherche de Vitry Alfortville, Vitry sur Seine, France
    Arterioscler Thromb Vasc Biol 16:1424-9. 1996
    ..These rabbits will be an extremely useful model for the evaluation of the effect of increased hepatic apo A-I expression on atherosclerosis...
  3. ncbi Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha
    A Mamontova
    INSERM U141 and IFR Circulation Lariboisière, Rhone Poulenc Rorer, Gencell Division, Atherosclerosis Department, Centre de recherches de Vitry Alfortville, France
    Circulation 98:2738-43. 1998
    ..Hypoalphalipoproteinemia is the most common lipoprotein abnormality in patients with coronary artery disease, yet its causes are unknown...